Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antidepressants for Depression and Frailty in Older Adults
NCT01973283Phase 4Completed
- Sponsor
- New York State Psychiatric Institute
- Start
- Feb 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of escitalopram, duloxetine in major depressive disorder (MDD), frailty syndrome, sponsored by New York State Psychiatric Institute. Started Feb 2014; status: completed.
02
Drugs
escitalopramduloxetine
03
Conditions
major depressive disorder (MDD)frailty syndrome
Beyond the preview
Go deeper on NCT01973283.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01973283.